Wells Fargo Cuts S&P 500 Target, Warns of Late-Cycle Risk

Wells Fargo just did something almost no major Wall Street firm has done in months: it cut its market forecast instead of raising it.

Strategist Ohsung Kwon and his team lowered their year-end S&P 500 target to 7,700 from 7,950 on Monday, implying barely 1% upside from where the index closed that day. It's a notable shift in tone after a year where most banks kept pushing targets higher.

The reasoning isn't about a near-term shock — it's about the calendar. Wells Fargo says the market is entering the "late innings" of a decade-long expansion cycle, a phase that historically comes with shrinking valuation multiples even when earnings keep growing.

And earnings have been growing fast. The S&P 500 posted 50% year-over-year earnings growth last quarter, a pace Wells Fargo doesn't think can continue. The firm actually raised its own earnings estimates, to $425 per share for 2027 and $460 for 2028, but flagged that 2027 estimates now sit about 42% above the historical trend line for this stage of the cycle — the widest gap since the 1950s.

That gap is the crux of the whole call. Wells Fargo isn't saying earnings will collapse — it's saying the market has priced in a growth rate that history says rarely persists this far into an expansion, and multiples tend to compress even when the underlying numbers stay decent.

"The bank also expressed concern that any deceleration in artificial intelligence capital expenditures by major technology corporations could negatively impact 2028 profit projections."

The call came right after Monday's tech-led selloff, triggered in part by AI industry figures publicly questioning the pace of AI development, which sent chip stocks and the Nasdaq lower alongside a 10-year Treasury yield that briefly touched 5%. Wells Fargo used that moment to downgrade technology from overweight to equal-weight, specifically favoring software companies over semiconductor makers within the sector.

The flip side of that trade is healthcare, which Wells Fargo upgraded to overweight from equal-weight. The firm points to potential political tailwinds — a Democratic midterm win could restore expanded Affordable Care Act subsidies, a boost for insurers and providers heading into 2027.

Healthcare has lagged the broader market this year, up about 9% compared to tech's 28% gain, which means Wells Fargo is essentially calling for a rotation from this year's biggest winner into one of its laggards. That's a contrarian bet, and contrarian bets don't always pay off on the timeline strategists expect.

Not every desk agrees with the cautious read. Bank of America moved in the opposite direction the same week, raising its own year-end S&P target to 7,400 from 7,100, even while warning that seasonal trends into year-end are historically unfavorable. That split between two major banks tells you this is a genuine debate, not a consensus call.

For retail investors, the actionable piece isn't about timing an exact top — it's about positioning. If you're overweight semiconductor names that have run hard this year, Wells Fargo's note is a reasonable prompt to trim into strength and rotate some of that exposure toward software or healthcare, sectors it sees as better risk-adjusted bets from here.

The risk in following this playbook too literally: AI capex deceleration is a forecast, not a fact yet. Company earnings so far this year have kept beating even skeptical estimates, and calling a "late-cycle" top has been a losing bet more than once in this market.

What to watch: this week's Fed decision and its effect on Treasury yields will likely set the tone for whether tech stocks stabilize or keep sliding. Also watch Q3 earnings season for early signs of whether AI capex commentary from the big hyperscalers softens — that's the tell Wells Fargo is explicitly flagging as the risk to 2028 profits.

Bottom line: Wells Fargo isn't calling for a crash, just a market that's earned less room to run — and a rotation out of chips and into software and healthcare might be the more defensible trade into year-end.